TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of Two Different Treatments for Lower Pore Renal Stone: Microperc Vs FURS
Brief Summary: This is a prospect, randomized control trial to evaluate merits between microperc and FURS for lower pole renal stone


Options:
A: Arm Label: tranexamic acid local; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tranexamic acid injection | Arm Label: tranexamic acid IV; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tranexamic acid injection | Intervention Type: DRUG; Name: Tranexamic acid injection; Assigned to Arm(s): tranexamic acid IV, tranexamic acid local
B: Arm Label: PCNL Group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: PCNL | Arm Label: mini-PCNL Group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: mini-PCNL | Arm Label: RIRS Group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: RIRS | Intervention Type: PROCEDURE; Name: PCNL; Assigned to Arm(s): PCNL Group | Intervention Type: PROCEDURE; Name: mini-PCNL; Assigned to Arm(s): mini-PCNL Group | Intervention Type: PROCEDURE; Name: RIRS; Assigned to Arm(s): RIRS Group
C: Arm Label: Group 1; Type: OTHER; Interventions: Procedure: Super-Mini Percutaneous Nephrolithotomy | Arm Label: Group 2; Type: OTHER; Interventions: Procedure: Retrograde Intrarenal Surgery | Intervention Type: PROCEDURE; Name: Super-Mini Percutaneous Nephrolithotomy; Assigned to Arm(s): Group 1 | Intervention Type: PROCEDURE; Name: Retrograde Intrarenal Surgery; Assigned to Arm(s): Group 2
D: Arm Label: Microperc surgery; Type: EXPERIMENTAL; Interventions: Procedure: Microperc surgery | Arm Label: FURS; Type: ACTIVE_COMPARATOR; Interventions: Procedure: FURS | Intervention Type: PROCEDURE; Name: Microperc surgery; Assigned to Arm(s): Microperc surgery | Intervention Type: PROCEDURE; Name: FURS; Assigned to Arm(s): FURS

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of Two Different Treatments for Lower Pore Renal Stone: Microperc Vs FURS
Brief Summary: This is a prospect, randomized control trial to evaluate merits between microperc and FURS for lower pole renal stone


Options:
A: Arm Label: Tranexamic acid; Type: EXPERIMENTAL; Interventions: Drug: Tranexamic Acid | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Tranexamic Acid; Assigned to Arm(s): Tranexamic acid | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: PCNL Group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: PCNL | Arm Label: mini-PCNL Group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: mini-PCNL | Arm Label: RIRS Group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: RIRS | Intervention Type: PROCEDURE; Name: PCNL; Assigned to Arm(s): PCNL Group | Intervention Type: PROCEDURE; Name: mini-PCNL; Assigned to Arm(s): mini-PCNL Group | Intervention Type: PROCEDURE; Name: RIRS; Assigned to Arm(s): RIRS Group
C: Arm Label: tranexamic acid local; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tranexamic acid injection | Arm Label: tranexamic acid IV; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tranexamic acid injection | Intervention Type: DRUG; Name: Tranexamic acid injection; Assigned to Arm(s): tranexamic acid IV, tranexamic acid local
D: Arm Label: Microperc surgery; Type: EXPERIMENTAL; Interventions: Procedure: Microperc surgery | Arm Label: FURS; Type: ACTIVE_COMPARATOR; Interventions: Procedure: FURS | Intervention Type: PROCEDURE; Name: Microperc surgery; Assigned to Arm(s): Microperc surgery | Intervention Type: PROCEDURE; Name: FURS; Assigned to Arm(s): FURS

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Suubi4Her: A Combination Intervention Addressing HIV Risk Behaviors Among Older Adolescent Girls Transitioning Into Adulthood in Uganda
Brief Summary: This study examines the impact and cost associated with Suubi4Her, an innovative combination intervention that aims to prevent HIV risk behaviors among 15-17 year-old girls living in communities heavily affected by poverty and HIV/AIDS in Uganda. Participants will be randomly assigned at the school level into one of three study conditions: 1) Savings (Youth Development Accounts - YDA) - with a 1:1 incentive match rate - for education and microenterprise development; 2) Savings (YDA) + Multiple Family Groups intervention; 3) Control condition receiving standard health and sex education provided in schools. The intervention will last for 24 months. Assessments will be conducted at baseline, 12, 24 and 36 months. Assessments will include biologically confirmed STIs, proportion of HIV infections during the study period, and for HIV+ participants markers for ART adherence. The study aims to examine the impact of the Suubi4Her intervention on behavioral health functioning, and protecting adolescent girls against known HIV risk factors. The study will also examine the cost-effectiveness of each intervention condition.


Options:
A: Arm Label: Livestock microfinance; Type: EXPERIMENTAL; Interventions: Behavioral: Livestock Microfinance | Arm Label: Delayed Control Group; Type: ACTIVE_COMPARATOR; Interventions: Other: Delayed Control Group | Intervention Type: BEHAVIORAL; Name: Livestock Microfinance; Assigned to Arm(s): Livestock microfinance | Intervention Type: OTHER; Name: Delayed Control Group; Assigned to Arm(s): Delayed Control Group
B: Arm Label: Step-by-Step; Type: EXPERIMENTAL; Interventions: Behavioral: Step-by-Step | Arm Label: Enhanced care as usual; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Enhanced care as usual | Intervention Type: BEHAVIORAL; Name: Step-by-Step; Assigned to Arm(s): Step-by-Step | Intervention Type: BEHAVIORAL; Name: Enhanced care as usual; Assigned to Arm(s): Enhanced care as usual
C: Arm Label: Youth Development Accounts (YDA); Type: EXPERIMENTAL; Interventions: Behavioral: Youth Development Accounts (YDA) | Arm Label: YDA + Multiple Family Groups (MFG); Type: EXPERIMENTAL; Interventions: Behavioral: YDA + Multiple Family Groups (MFG) | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Youth Development Accounts (YDA); Assigned to Arm(s): Youth Development Accounts (YDA) | Intervention Type: BEHAVIORAL; Name: YDA + Multiple Family Groups (MFG); Assigned to Arm(s): YDA + Multiple Family Groups (MFG)
D: Arm Label: THPP-I; Type: EXPERIMENTAL; Interventions: Behavioral: THPP-I, Behavioral: EUC | Arm Label: Enhanced usual care (EUC); Type: OTHER; Interventions: Behavioral: EUC | Intervention Type: BEHAVIORAL; Name: THPP-I; Assigned to Arm(s): THPP-I | Intervention Type: BEHAVIORAL; Name: EUC; Assigned to Arm(s): Enhanced usual care (EUC), THPP-I

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Aneurysmal Subarachnoid Hemorrhage - Red Blood Cell Transfusion and Outcome (SAHaRA): A Randomized Controlled Trial
Brief Summary: The SAHaRA trial will clarify the role of treating anemia with Red Blood Cell (RBC) transfusion in a unique and vulnerable patient population, and determine whether that impacts on functional outcomes and mortality. It will guide best practice standards and clarify the optimal RBC transfusion strategy in patients with aSAH.


Options:
A: Arm Label: Restrictive arm (intervention); Type: EXPERIMENTAL; Interventions: Procedure: Less red blood cell transfusions | Arm Label: Standard care arm (comparator); Type: ACTIVE_COMPARATOR; Interventions: Procedure: More red blood cell transfusion (standard transfusion strategy in PICU) | Intervention Type: PROCEDURE; Name: Less red blood cell transfusions; Assigned to Arm(s): Restrictive arm (intervention) | Intervention Type: PROCEDURE; Name: More red blood cell transfusion (standard transfusion strategy in PICU); Assigned to Arm(s): Standard care arm (comparator)
B: Arm Label: Liberal RBC Transfusion Strategy; Type: EXPERIMENTAL; Interventions: Other: Liberal RBC Transfusion Strategy | Arm Label: Restrictive RBC Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Restrictive RBC Transfusion Strategy | Intervention Type: OTHER; Name: Liberal RBC Transfusion Strategy; Assigned to Arm(s): Liberal RBC Transfusion Strategy | Intervention Type: OTHER; Name: Restrictive RBC Transfusion Strategy; Assigned to Arm(s): Restrictive RBC Transfusion Strategy
C: Arm Label: Restrictive; Type: EXPERIMENTAL; Interventions: Procedure: Blood Transfusion | Arm Label: Liberal; Type: EXPERIMENTAL; Interventions: Procedure: Blood Transfusion | Intervention Type: PROCEDURE; Name: Blood Transfusion; Assigned to Arm(s): Liberal, Restrictive
D: Arm Label: Liberal; Type: ACTIVE_COMPARATOR; Interventions: Other: Liberal transfusion threshold | Arm Label: Restrictive; Type: ACTIVE_COMPARATOR; Interventions: Other: Restrictive transfusion threshold | Intervention Type: OTHER; Name: Restrictive transfusion threshold; Assigned to Arm(s): Restrictive | Intervention Type: OTHER; Name: Liberal transfusion threshold; Assigned to Arm(s): Liberal

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Aneurysmal Subarachnoid Hemorrhage - Red Blood Cell Transfusion and Outcome (SAHaRA): A Randomized Controlled Trial
Brief Summary: The SAHaRA trial will clarify the role of treating anemia with Red Blood Cell (RBC) transfusion in a unique and vulnerable patient population, and determine whether that impacts on functional outcomes and mortality. It will guide best practice standards and clarify the optimal RBC transfusion strategy in patients with aSAH.


Options:
A: Arm Label: Red blood cell transfusion; Type: ACTIVE_COMPARATOR; Interventions: Other: Red blood cell transfusion | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Red blood cell transfusion; Assigned to Arm(s): Red blood cell transfusion
B: Arm Label: Liberal RBC Transfusion Strategy; Type: EXPERIMENTAL; Interventions: Other: Liberal RBC Transfusion Strategy | Arm Label: Restrictive RBC Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Restrictive RBC Transfusion Strategy | Intervention Type: OTHER; Name: Liberal RBC Transfusion Strategy; Assigned to Arm(s): Liberal RBC Transfusion Strategy | Intervention Type: OTHER; Name: Restrictive RBC Transfusion Strategy; Assigned to Arm(s): Restrictive RBC Transfusion Strategy
C: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Packed Red Blood Cell Transfusion | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Procedure: Packed Red Blood Cell Transfusion | Intervention Type: PROCEDURE; Name: Packed Red Blood Cell Transfusion; Assigned to Arm(s): 1, 2
D: Arm Label: Single-Unit Blood Transfusion Protocol; Type: ACTIVE_COMPARATOR; Interventions: Biological: Blood Transfusion | Arm Label: Multiple-Unit Blood Transfusion Protocol; Type: ACTIVE_COMPARATOR; Interventions: Biological: Blood Transfusion | Intervention Type: BIOLOGICAL; Name: Blood Transfusion; Assigned to Arm(s): Multiple-Unit Blood Transfusion Protocol, Single-Unit Blood Transfusion Protocol

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Aneurysmal Subarachnoid Hemorrhage - Red Blood Cell Transfusion and Outcome (SAHaRA): A Randomized Controlled Trial
Brief Summary: The SAHaRA trial will clarify the role of treating anemia with Red Blood Cell (RBC) transfusion in a unique and vulnerable patient population, and determine whether that impacts on functional outcomes and mortality. It will guide best practice standards and clarify the optimal RBC transfusion strategy in patients with aSAH.


Options:
A: Arm Label: Blood transfusion; Type: EXPERIMENTAL; Interventions: Biological: Blood transfusion | Intervention Type: BIOLOGICAL; Name: Blood transfusion; Assigned to Arm(s): Blood transfusion
B: Arm Label: Liberal RBC Transfusion Strategy; Type: EXPERIMENTAL; Interventions: Other: Liberal RBC Transfusion Strategy | Arm Label: Restrictive RBC Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Restrictive RBC Transfusion Strategy | Intervention Type: OTHER; Name: Liberal RBC Transfusion Strategy; Assigned to Arm(s): Liberal RBC Transfusion Strategy | Intervention Type: OTHER; Name: Restrictive RBC Transfusion Strategy; Assigned to Arm(s): Restrictive RBC Transfusion Strategy
C: Arm Label: Restrictive arm (intervention); Type: EXPERIMENTAL; Interventions: Procedure: Less red blood cell transfusions | Arm Label: Standard care arm (comparator); Type: ACTIVE_COMPARATOR; Interventions: Procedure: More red blood cell transfusion (standard transfusion strategy in PICU) | Intervention Type: PROCEDURE; Name: Less red blood cell transfusions; Assigned to Arm(s): Restrictive arm (intervention) | Intervention Type: PROCEDURE; Name: More red blood cell transfusion (standard transfusion strategy in PICU); Assigned to Arm(s): Standard care arm (comparator)
D: Arm Label: Restrictive; Type: EXPERIMENTAL; Interventions: Procedure: Blood Transfusion | Arm Label: Liberal; Type: EXPERIMENTAL; Interventions: Procedure: Blood Transfusion | Intervention Type: PROCEDURE; Name: Blood Transfusion; Assigned to Arm(s): Liberal, Restrictive

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Homestead Agriculture and Nutrition Project in Rufiji District, Tanzania
Brief Summary: HANU is an evaluation of the effects of an integrated, gender-focused nutrition-sensitive intervention on the nutrition and health of young children and women of reproductive age in rural Tanzania.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Peer-support for exclusive breastfeeding | Arm Label: No intervention; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Peer-support for exclusive breastfeeding; Assigned to Arm(s): Intervention
B: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Nutrition-sensitive intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Nutrition-sensitive intervention; Assigned to Arm(s): Intervention
C: Arm Label: Routine health education; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Routine health education | Arm Label: Nutrition education package; Type: EXPERIMENTAL; Interventions: Behavioral: Nutrition education, Behavioral: Routine health education | Intervention Type: BEHAVIORAL; Name: Nutrition education; Assigned to Arm(s): Nutrition education package | Intervention Type: BEHAVIORAL; Name: Routine health education; Assigned to Arm(s): Nutrition education package, Routine health education
D: Arm Label: Training of VHVs in iCCM; Type: EXPERIMENTAL; Interventions: Other: Training of VHVs in iCCM | Intervention Type: OTHER; Name: Training of VHVs in iCCM; Assigned to Arm(s): Training of VHVs in iCCM

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A European, Prospective, Multi-Center, Double-Blind, Randomized, Controlled, Clinical Trial Investigating the Effects of High Frequency Wireless Spinal Cord Stimulation (SCS) Over Exiting Nerve Roots in the Treatment of Chronic Back Pain
Brief Summary: Prospective, double blinded, randomized, clinical study investigating the effects of high frequency SCS over exiting nerve roots at T9 for the treatment of chronic back or back and leg pain.


Options:
A: Arm Label: Sham; Type: SHAM_COMPARATOR; Interventions: Device: Sham | Arm Label: 1200 Hz; Type: EXPERIMENTAL; Interventions: Device: 1200 Hz | Arm Label: 3030 Hz; Type: EXPERIMENTAL; Interventions: Device: 3030 Hz | Arm Label: 5882 Hz; Type: EXPERIMENTAL; Interventions: Device: 5882 Hz | Intervention Type: DEVICE; Name: Sham; Assigned to Arm(s): Sham | Intervention Type: DEVICE; Name: 1200 Hz; Assigned to Arm(s): 1200 Hz | Intervention Type: DEVICE; Name: 3030 Hz; Assigned to Arm(s): 3030 Hz | Intervention Type: DEVICE; Name: 5882 Hz; Assigned to Arm(s): 5882 Hz
B: Arm Label: Burst SCS; Type: EXPERIMENTAL; Interventions: Procedure: Burst Spinal Cord Stimulation, Procedure: Sham spinal cord stimulation, Device: SCS implant | Arm Label: Sham SCS; Type: SHAM_COMPARATOR; Interventions: Procedure: Burst Spinal Cord Stimulation, Procedure: Sham spinal cord stimulation, Device: SCS implant | Intervention Type: PROCEDURE; Name: Burst Spinal Cord Stimulation; Assigned to Arm(s): Burst SCS, Sham SCS | Intervention Type: PROCEDURE; Name: Sham spinal cord stimulation; Assigned to Arm(s): Burst SCS, Sham SCS | Intervention Type: DEVICE; Name: SCS implant; Assigned to Arm(s): Burst SCS, Sham SCS
C: Intervention Type: DEVICE; Name: Medtronic Manufactured Spinal Cord Stimulators; Assigned to Arm(s): N/A
D: Arm Label: High Frequency; Type: EXPERIMENTAL; Interventions: Device: Spinal Cord Stimulator HF | Arm Label: Sham; Type: SHAM_COMPARATOR; Interventions: Device: Spinal Cord Stimulator Sham | Intervention Type: DEVICE; Name: Spinal Cord Stimulator HF; Assigned to Arm(s): High Frequency | Intervention Type: DEVICE; Name: Spinal Cord Stimulator Sham; Assigned to Arm(s): Sham

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A European, Prospective, Multi-Center, Double-Blind, Randomized, Controlled, Clinical Trial Investigating the Effects of High Frequency Wireless Spinal Cord Stimulation (SCS) Over Exiting Nerve Roots in the Treatment of Chronic Back Pain
Brief Summary: Prospective, double blinded, randomized, clinical study investigating the effects of high frequency SCS over exiting nerve roots at T9 for the treatment of chronic back or back and leg pain.


Options:
A: Arm Label: Burst-SCS/sham SCS; Type: OTHER; Interventions: Device: Burst-SCS, Device: Sham SCS | Arm Label: Sham SCS/Burst-SCS; Type: OTHER; Interventions: Device: Burst-SCS, Device: Sham SCS | Intervention Type: DEVICE; Name: Burst-SCS; Assigned to Arm(s): Burst-SCS/sham SCS, Sham SCS/Burst-SCS | Intervention Type: DEVICE; Name: Sham SCS; Assigned to Arm(s): Burst-SCS/sham SCS, Sham SCS/Burst-SCS
B: Arm Label: SHAM; Type: SHAM_COMPARATOR; Interventions: Device: Spinal cord stimulation | Arm Label: High Density Stimulation; Type: EXPERIMENTAL; Interventions: Device: Spinal cord stimulation | Arm Label: Conventional stimulation; Type: ACTIVE_COMPARATOR; Interventions: Device: Spinal cord stimulation | Intervention Type: DEVICE; Name: Spinal cord stimulation; Assigned to Arm(s): Conventional stimulation, High Density Stimulation, SHAM
C: Arm Label: High Frequency; Type: EXPERIMENTAL; Interventions: Device: Spinal Cord Stimulator HF | Arm Label: Sham; Type: SHAM_COMPARATOR; Interventions: Device: Spinal Cord Stimulator Sham | Intervention Type: DEVICE; Name: Spinal Cord Stimulator HF; Assigned to Arm(s): High Frequency | Intervention Type: DEVICE; Name: Spinal Cord Stimulator Sham; Assigned to Arm(s): Sham
D: Arm Label: Burst SCS; Type: ACTIVE_COMPARATOR; Interventions: Device: Burst SCS (Abbott Proclaim IPG and single lead Abbott Octrode at level Th9/10) | Arm Label: Sham; Type: SHAM_COMPARATOR; Interventions: Device: Burst SCS (Abbott Proclaim IPG and single lead Abbott Octrode at level Th9/10) | Intervention Type: DEVICE; Name: Burst SCS (Abbott Proclaim IPG and single lead Abbott Octrode at level Th9/10); Assigned to Arm(s): Burst SCS, Sham

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A European, Prospective, Multi-Center, Double-Blind, Randomized, Controlled, Clinical Trial Investigating the Effects of High Frequency Wireless Spinal Cord Stimulation (SCS) Over Exiting Nerve Roots in the Treatment of Chronic Back Pain
Brief Summary: Prospective, double blinded, randomized, clinical study investigating the effects of high frequency SCS over exiting nerve roots at T9 for the treatment of chronic back or back and leg pain.


Options:
A: Arm Label: Sequence 1; Type: OTHER; Interventions: Device: High frequency spinal cord stimulation | Arm Label: Sequence 2; Type: OTHER; Interventions: Device: High frequency spinal cord stimulation | Intervention Type: DEVICE; Name: High frequency spinal cord stimulation; Assigned to Arm(s): Sequence 1, Sequence 2
B: Arm Label: High Frequency; Type: EXPERIMENTAL; Interventions: Device: Spinal Cord Stimulator HF | Arm Label: Sham; Type: SHAM_COMPARATOR; Interventions: Device: Spinal Cord Stimulator Sham | Intervention Type: DEVICE; Name: Spinal Cord Stimulator HF; Assigned to Arm(s): High Frequency | Intervention Type: DEVICE; Name: Spinal Cord Stimulator Sham; Assigned to Arm(s): Sham
C: Arm Label: Sham; Type: SHAM_COMPARATOR; Interventions: Device: Sham | Arm Label: 1200 Hz; Type: EXPERIMENTAL; Interventions: Device: 1200 Hz | Arm Label: 3030 Hz; Type: EXPERIMENTAL; Interventions: Device: 3030 Hz | Arm Label: 5882 Hz; Type: EXPERIMENTAL; Interventions: Device: 5882 Hz | Intervention Type: DEVICE; Name: Sham; Assigned to Arm(s): Sham | Intervention Type: DEVICE; Name: 1200 Hz; Assigned to Arm(s): 1200 Hz | Intervention Type: DEVICE; Name: 3030 Hz; Assigned to Arm(s): 3030 Hz | Intervention Type: DEVICE; Name: 5882 Hz; Assigned to Arm(s): 5882 Hz
D: Arm Label: HF/TCS/BURST; Type: EXPERIMENTAL; Interventions: Device: Precision Spectra™ system | Arm Label: HF/BURST/TCS; Type: EXPERIMENTAL; Interventions: Device: Precision Spectra™ system | Arm Label: BURST/HF/TCS; Type: EXPERIMENTAL; Interventions: Device: Precision Spectra™ system | Arm Label: BURST/TCS/HF; Type: EXPERIMENTAL; Interventions: Device: Precision Spectra™ system | Arm Label: TCS/BURST/HF; Type: EXPERIMENTAL; Interventions: Device: Precision Spectra™ system | Arm Label: TCS/HF/BURST; Type: EXPERIMENTAL; Interventions: Device: Precision Spectra™ system | Intervention Type: DEVICE; Name: Precision Spectra™ system; Assigned to Arm(s): BURST/HF/TCS, BURST/TCS/HF, HF/BURST/TCS, HF/TCS/BURST, TCS/BURST/HF, TCS/HF/BURST

Answer: B